<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36316501</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0048</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nature reviews. Neuroscience</Title><ISOAbbreviation>Nat Rev Neurosci</ISOAbbreviation></Journal><ArticleTitle>Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders.</ArticleTitle><Pagination><StartPage>23</StartPage><EndPage>39</EndPage><MedlinePgn>23-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41583-022-00641-1</ELocationID><Abstract><AbstractText>There is increasing appreciation that non-neuronal cells contribute to the initiation, progression and pathology of diverse neurodegenerative disorders. This Review focuses on the role of astrocytes in disorders including Alzheimer disease, Parkinson disease, Huntington disease and amyotrophic lateral sclerosis. The important roles astrocytes have in supporting neuronal function in the healthy brain are considered, along with studies that have demonstrated how the physiological properties of astrocytes are altered in neurodegenerative disorders and may explain their contribution to neurodegeneration. Further, the question of whether in neurodegenerative disorders with specific genetic mutations these mutations directly impact on astrocyte function, and may suggest a driving role for astrocytes in disease initiation, is discussed. A summary of how astrocyte transcriptomic and proteomic signatures are altered during the progression of neurodegenerative disorders and may relate to functional changes is provided. Given the central role of astrocytes in neurodegenerative disorders, potential strategies to target these cells for future therapeutic avenues are discussed.</AbstractText><CopyrightInformation>&#xa9; 2022. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Brandebura</LastName><ForeName>Ashley N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0001-9862-0977</Identifier><AffiliationInfo><Affiliation>Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Paumier</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Onur</LastName><ForeName>Tarik S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Nicola J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-7542-5930</Identifier><AffiliationInfo><Affiliation>Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA. nallen@salk.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 NS117776</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Neurosci</MedlineTA><NlmUniqueID>100962781</NlmUniqueID><ISSNLinking>1471-003X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36316501</ArticleId><ArticleId IdType="mid">NIHMS1895862</ArticleId><ArticleId IdType="pmc">PMC10198620</ArticleId><ArticleId IdType="doi">10.1038/s41583-022-00641-1</ArticleId><ArticleId IdType="pii">10.1038/s41583-022-00641-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allen NJ Role of glia in developmental synapse formation. Current opinion in neurobiology 23, 1027&#x2013;1033 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23871217</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen NJ &amp; Eroglu C Cell Biology of Astrocyte-Synapse Interactions. Neuron 96, 697&#x2013;708 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5687890</ArticleId><ArticleId IdType="pubmed">29096081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung W-S, Allen NJ &amp; Eroglu C Astrocytes Control Synapse Formation, Function, and Elimination. Cold Spring Harb Perspect Biol 7, a020370 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4527946</ArticleId><ArticleId IdType="pubmed">25663667</ArticleId></ArticleIdList></Reference><Reference><Citation>Khakh BS &amp; Sofroniew MV Diversity of astrocyte functions and phenotypes in neural circuits Nature Neuroscience 18, 942&#x2013;952 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5258184</ArticleId><ArticleId IdType="pubmed">26108722</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopherson KS et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421&#x2013;433 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15707899</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen NJ et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486, 410&#x2013;414 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383085</ArticleId><ArticleId IdType="pubmed">22722203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung W-S et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394&#x2013;400 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969024</ArticleId><ArticleId IdType="pubmed">24270812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucukdereli H et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proceedings of the National Academy of Sciences 108, E440&#x2013;E449 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3156217</ArticleId><ArticleId IdType="pubmed">21788491</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Suarez E, Liu T-F, Kopelevich A &amp; Allen NJ Astrocyte-Secreted Chordin-like 1 Drives Synapse Maturation and Limits Plasticity by Increasing Synaptic GluA2 AMPA Receptors. Neuron 100, 1116&#x2013;1132.e1113 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382071</ArticleId><ArticleId IdType="pubmed">30344043</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B &amp; Barros LF The Astrocyte: Powerhouse and Recycling Center. Cold Spring Harb Perspect Biol 7, a020396 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4665076</ArticleId><ArticleId IdType="pubmed">25680832</ArticleId></ArticleIdList></Reference><Reference><Citation>Profaci CP, Munji RN, Pulido RS &amp; Daneman R The blood-brain barrier in health and disease: Important unanswered questions. J Exp Med 217, e20190062 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144528</ArticleId><ArticleId IdType="pubmed">32211826</ArticleId></ArticleIdList></Reference><Reference><Citation>Araque A et al. Gliotransmitters travel in time and space. Neuron 81, 728&#x2013;739 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107238</ArticleId><ArticleId IdType="pubmed">24559669</ArticleId></ArticleIdList></Reference><Reference><Citation>Boisvert M, Erikson G, Shokhirev M &amp; Allen N The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain. Cell Reports 22, 269&#x2013;285 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5783200</ArticleId><ArticleId IdType="pubmed">29298427</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke LE et al. Normal aging induces A1-like astrocyte reactivity. Proceedings of the National Academy of Sciences of the United States of America 115, E1896&#x2013;E1905 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5828643</ArticleId><ArticleId IdType="pubmed">29437957</ArticleId></ArticleIdList></Reference><Reference><Citation>Orre M et al. Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiology of Aging 35, 1&#x2013;14 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">23954174</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-castro B, Gangwani MR, Yu X, Coppola G &amp; Khakh BS Astrocyte molecular signatures in Huntington&#x2019;s disease. Science Translational Medicine 11, eaaw8546 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31619545</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalahmah O et al. Single-nucleus RNA-seq identifies Huntington disease astrocyte states. Acta Neuropathologica Communications 8, 19 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029580</ArticleId><ArticleId IdType="pubmed">32070434</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N et al. Disease-associated astrocytes in Alzheimer&#x2019;s disease and aging. Nature Neuroscience 23, 701&#x2013;706 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262034</ArticleId><ArticleId IdType="pubmed">32341542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau S-F, Cao H, Fu AKY &amp; Ip NY Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer&#x2019;s disease. Proceedings of the National Academy of Sciences 117, 25800&#x2013;25809 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7568283</ArticleId><ArticleId IdType="pubmed">32989152</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K et al. Molecular characterization of selectively vulnerable neurons in Alzheimer&#x2019;s disease. Nature Neuroscience 24, 276&#x2013;287 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854528</ArticleId><ArticleId IdType="pubmed">33432193</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang R, Diaz-Castro B, Looger LL &amp; Khakh BS Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington&#x2019;s Disease Model Mice. Journal of Neuroscience 36, 3453&#x2013;3470 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4804005</ArticleId><ArticleId IdType="pubmed">27013675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonninen TM et al. Metabolic alterations in Parkinson &#x2018; s disease astrocytes. Scientific Reports 10, 14474 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7468111</ArticleId><ArticleId IdType="pubmed">32879386</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P et al. Mitochondrial Dysfunction in SOD1G93A-Bearing Astrocytes Promotes Motor Neuron Degeneration: Prevention by Mitochondrial-Targeted Antioxidants. The Journal of Neuroscience 28, 4115&#x2013;4122 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3844766</ArticleId><ArticleId IdType="pubmed">18417691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae JR &amp; Kim SH Synapses in neurodegenerative diseases. BMB Reports 50, 237&#x2013;246 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5458673</ArticleId><ArticleId IdType="pubmed">28270301</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C et al. Reactive astrocyte nomenclature, definitions, and future directions. Nature Neuroscience 24, 312&#x2013;325 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson MR, Fuertes CJA, Dunn AK, Drew MR &amp; Jones TA Reactive astrocytes facilitate vascular repair and remodeling after stroke. Cell Reports 35, 109048 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142687</ArticleId><ArticleId IdType="pubmed">33910014</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z et al. Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke. Glia 62, 2022&#x2013;2033 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307923</ArticleId><ArticleId IdType="pubmed">25043249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft AW et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB Journal 27, 187&#x2013;198 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528309</ArticleId><ArticleId IdType="pubmed">23038755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian JL et al. Genomic Analysis of Reactive Astrogliosis. The Journal of neuroscience 32, 6391&#x2013;6410 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang AYS et al. Region-Specific Transcriptional Control of Astrocyte Function Oversees Local Circuit Activities. Neuron 106, 992&#x2013;1008.e1009 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879989</ArticleId><ArticleId IdType="pubmed">32320644</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai H. h. et al. Regional Astrocyte Allocation Regulates CNS Synaptogenesis and Repair. Science 337, 358&#x2013;362 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4059181</ArticleId><ArticleId IdType="pubmed">22745251</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer TA Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders? European Neuropsychopharmacology 25, 713&#x2013;724 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">23642796</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proceedings of the National Academy of Sciences 110, 4697&#x2013;4702 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach TG &amp; McGeer EG Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer&#x2019;s disease visual cortex. Brain Research 463, 357&#x2013;361 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">3196922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosson A et al. TRPA1 channels promote astrocytic Ca 2 + hyperactivity and synaptic dysfunction mediated by oligomeric forms of amyloid- &#x3b2; peptide. Molecular Neurodegeneration 12, 53 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501536</ArticleId><ArticleId IdType="pubmed">28683776</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Nievas BG &amp; Serrano-Pozo A Deciphering the Astrocyte Reaction in Alzheimer&#x2019;s Disease. Frontiers in Aging Neuroscience 10, 114 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5996928</ArticleId><ArticleId IdType="pubmed">29922147</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff JJ et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid &#x3b2;. Science Translational Medicine 4, 147ra111 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551275</ArticleId><ArticleId IdType="pubmed">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiry-Moghaddam M &amp; Ottersen OP The Molecular Basis of Water Transport in the Brain. Nature Reviews Neuroscience 4, 991&#x2013;1001 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14682361</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron NS et al. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease. J Neurosci 41, 780&#x2013;796 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7842749</ArticleId><ArticleId IdType="pubmed">33310753</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong X et al. Astrocyte Kir4 . 1 ion channel deficits contribute to neuronal dysfunction in Huntington &#x2018; s disease model mice. Nature Neuroscience 17, 694&#x2013;703 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4064471</ArticleId><ArticleId IdType="pubmed">24686787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshi A et al. Characteristics of Aquaporin Expression Surrounding Senile Plaques and Cerebral Amyloid Angiopathy in Alzheimer Disease. Journal of Neuropathology &amp; Experimental Neurology 71, 750&#x2013;759 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22805778</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z et al. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain A&#x3b2; accumulation and memory deficits. Molecular Neurodegeneration 10, 58 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631089</ArticleId><ArticleId IdType="pubmed">26526066</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano JM et al. Human apoE Isoforms Differentially Regulate Brain Amyloid- b Peptide Clearance. Science Translational Medicine 3, 89ra57 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3192364</ArticleId><ArticleId IdType="pubmed">21715678</ArticleId></ArticleIdList></Reference><Reference><Citation>Streubel-Gallasch L et al. Parkinson&#x2019;s Disease&#x2013;Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance. Molecular Neurobiology 58, 3119&#x2013;3140 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257537</ArticleId><ArticleId IdType="pubmed">33629273</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A &amp; Nedergaard M Physiology of astroglia. Physiological Reviews 98, 239&#x2013;389 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050349</ArticleId><ArticleId IdType="pubmed">29351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindocci E et al. Three-dimensional Ca 2+ imaging advances understanding of astrocyte biology. Science 356, eaai8185 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28522470</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenbach A, Derouiche A &amp; Kirchhoff F Morphology and dynamics of perisynaptic glia. Brain Research Reviews 63, 11&#x2013;25 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20176054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H et al. Abnormal Intracellular Calcium Signaling and SNARE- Dependent Exocytosis Contributes to SOD1G93A Astrocyte- Mediated Toxicity in Amyotrophic Lateral Sclerosis. The Journal of neuroscience 34, 2331&#x2013;2348 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F, Brambilla L, Valori CF &amp; Bergamaschi C The BH4 domain of Bcl-X L rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Human Molecular Genetics 21, 826&#x2013;840 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22072391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosson A, Boisseau S, Buisson A, Savasta M &amp; Albrieux M Disruption of dopaminergic transmission remodels tripartite synapse morphology and astrocytic calcium activity within substantia nigra pars reticulata. Glia 63, 673&#x2013;683 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25511180</ArticleId></ArticleIdList></Reference><Reference><Citation>Paumier A et al. Astrocyte&#x2013;neuron interplay is critical for Alzheimer&#x2019;s disease pathogenesis and is rescued by TRPA1 channel blockade. Brain 145, 388&#x2013;405 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34302466</ArticleId></ArticleIdList></Reference><Reference><Citation>Panatier A et al. Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 146, 785&#x2013;798 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21855979</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenbach N et al. P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer &#x2018; s disease model. Journal of Experimental Medicine 215, 1649&#x2013;1663 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5987918</ArticleId><ArticleId IdType="pubmed">29724785</ArticleId></ArticleIdList></Reference><Reference><Citation>Danbolt NC Glutamate uptake. Progress in Neurobiology 65, 1&#x2013;105 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11369436</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajarillo E, Rizor A, Lee J, Aschner M &amp; Lee E The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders : Potential targets for neurotherapeutics. Neuropharmacology 161, 107559 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6731169</ArticleId><ArticleId IdType="pubmed">30851309</ArticleId></ArticleIdList></Reference><Reference><Citation>Iovino L et al. Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson&#x2019;s disease. Acta Neuropathol 144, 81&#x2013;106 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9217889</ArticleId><ArticleId IdType="pubmed">35596783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y et al. Generation of a Novel Mouse Model of Parkinson&#x2019;s Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra. ACS Chemical Neuroscience 11, 406&#x2013;417 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31909584</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren C et al. Induction of Parkinsonian-Like Changes via Targeted Downregulation of Astrocytic Glutamate Transporter GLT-1 in the Striatum. Journal of Parkinson&#x2019;s Disease 12, 295&#x2013;314 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34719508</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney JW Glutamate-induced Neuronal Necrosis in the Infant Mouse Hypothalamus. Journal of Neuropathology &amp; Experimental Neurology 30, 75&#x2013;90 (1971).</Citation><ArticleIdList><ArticleId IdType="pubmed">5542543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, d&#x2019;Ydewalle C &amp; Van Den Bosch L Amyotrophic Lateral Sclerosis and Excitotoxicity : From Pathological Mechanism to Therapeutic Target. CNS Neurol Disord Drug Targets 9, 297&#x2013;304 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20406181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynd MR, Scott HL &amp; Dodd PR Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer &#x2018; s disease. Neurochemistry International 45, 583&#x2013;595 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15234100</ArticleId></ArticleIdList></Reference><Reference><Citation>Iovino L, Tremblay ME &amp; Civiero L Glutamate-induced excitotoxicity in Parkinson &#x2018; s disease : The role of glial cells. Journal of Pharmacological Science 144, 151&#x2013;164 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32807662</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepers MD &amp; Raymond LA Mechanisms of synaptic dysfunction and excitotoxicity in Huntington &#x2018; s disease. Drug Discovery Today 19, 990&#x2013;996 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24603212</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura CA, Parra-Damas A &amp; Enriquez-Barreto L Gene expression parallels synaptic excitability and plasticity changes in Alzheimer&#x2019;s disease. Frontiers in Cellular Neuroscience 9, 318 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4548151</ArticleId><ArticleId IdType="pubmed">26379494</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD et al. Physical basis of cognitive alterations in alzheimer&#x2019;s disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology 30, 572&#x2013;580 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>Esquerda-Canals G, Montoliu-Gaya L, G&#xfc;ell-Bosch J &amp; Villegas S Mouse Models of Alzheimer&#x2019;s Disease. Journal of Alzheimer&#x2019;s Disease 57, 1171&#x2013;1183 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28304309</ArticleId></ArticleIdList></Reference><Reference><Citation>Henstridge CM, Tzioras M &amp; Paolicelli RC Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration. Frontiers in Cellular Neuroscience 13, 63 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6399113</ArticleId><ArticleId IdType="pubmed">30863284</ArticleId></ArticleIdList></Reference><Reference><Citation>Talantova M et al. A&#x3b2; induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proceedings of the National Academy of Sciences of the United States of America 110, E2518&#x2013;2527 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3704025</ArticleId><ArticleId IdType="pubmed">23776240</ArticleId></ArticleIdList></Reference><Reference><Citation>Trudler D et al. &#x3b1;-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss. The Journal of Neuroscience 41, 2264&#x2013;2273 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8018774</ArticleId><ArticleId IdType="pubmed">33483428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardingham GE &amp; Bading H Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11, 682&#x2013;696 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2948541</ArticleId><ArticleId IdType="pubmed">20842175</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava AN et al. b -Amyloid and ATP-Induced Diffusional Trapping of Astrocyte and Neuronal Metabotropic Glutamate Type-5 Receptors. Glia 61, 1673&#x2013;1686 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23922225</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo S et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer&#x2019;s disease. Nature medicine 20, 886&#x2013;896 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385452</ArticleId><ArticleId IdType="pubmed">24973918</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Castro MA et al. Local Ca2+ detection and modulation of synaptic release by astrocytes. Nature Neuroscience 14, 1276&#x2013;1284 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21909085</ArticleId></ArticleIdList></Reference><Reference><Citation>Minelli A et al. Cellular and subcellular localization of Na + &#x2013; Ca 2 + exchanger protein isoforms, NCX1, NCX2, and NCX3 in cerebral cortex and hippocampus of adult rat. Cell Calcium 41, 221&#x2013;234 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">16914199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucheryavykh YV et al. Downregulation of Kir4 . 1 Inward Rectifying Potassium Channel Subunits by RNAi Impairs Potassium Transfer and Glutamate Uptake by Cultured Cortical Astrocytes. Glia 55, 274&#x2013;281 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17091490</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzilotti S et al. Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na + / Ca 2 + exchanger 3 downregulation. Cell Death and Disease 9, 206 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833681</ArticleId><ArticleId IdType="pubmed">29434186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannaccione A et al. A New Concept : AB1 &#x2013; 42 Generates a Hyperfunctional Proteolytic NCX3 Fragment That Delays Caspase-12 Activation and Neuronal Death. The Journal of neuroscience 32, 10609&#x2013;10617 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6621392</ArticleId><ArticleId IdType="pubmed">22855810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley KW et al. Kir4.1-Dependent Astrocyte-Fast Motor Neuron Interactions Are Required for Peak Strength. Neuron 98, 306&#x2013;319.e307 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5919779</ArticleId><ArticleId IdType="pubmed">29606582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang BL Glucose, glycolysis, and neurodegenerative diseases. Journal of Cell Physiology 235, 7653&#x2013;7662 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32239718</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;langer M, Allaman I &amp; Magistretti PJ Brain Energy Metabolism : Focus on Astrocyte-Neuron Metabolic Cooperation. Cell Metabolism 14, 724&#x2013;738 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22152301</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki A et al. Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation. Cell 144, 810&#x2013;823 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073831</ArticleId><ArticleId IdType="pubmed">21376239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J et al. Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons. Proceedings of the National Academy of Sciences 111, 12228&#x2013;12233 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4143009</ArticleId><ArticleId IdType="pubmed">25071212</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterwald C, Magistretti PJ &amp; Lengacher S Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases. Curr Pharm Des 21, 3570&#x2013;3581 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26166612</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen JA, Halverson-tamboli RA &amp; Rasenick MM Lipid raft microdomains and neurotransmitter signalling. Nature Reviews Neuroscience 8, 128&#x2013;140 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17195035</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfrieger FW &amp; Ungerer N Cholesterol metabolism in neurons and astrocytes. Progress in Lipid Research 50, 357&#x2013;371 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21741992</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman EM et al. Correlations between apolipoprotein E4 gene dose and brain-imaging measurements of regional hypometabolism. Proceedings of the National Academy of Sciences 102, 8299&#x2013;8302 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1149416</ArticleId><ArticleId IdType="pubmed">15932949</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams HC et al. APOE alters glucose flux through central carbon pathways in astrocytes. Neurobiology of Disease 136, 104742 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7044721</ArticleId><ArticleId IdType="pubmed">31931141</ArticleId></ArticleIdList></Reference><Reference><Citation>Larramona-Arcas R et al. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice. Molecular Neurodegeneration 15, 35 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7285605</ArticleId><ArticleId IdType="pubmed">32517777</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong W, Lee H, Cho S &amp; Seo J ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer &#x2018; s Disease. Molecules and cells 42, 739&#x2013;746 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6883979</ArticleId><ArticleId IdType="pubmed">31711277</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenza M et al. Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington &#x2018; s disease. Cell Death and Differentiation 22, 690&#x2013;702 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356339</ArticleId><ArticleId IdType="pubmed">25301063</ArticleId></ArticleIdList></Reference><Reference><Citation>Birolini G et al. SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington&#x2019;s disease phenotypes. Brain 144, 3175&#x2013;3190 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33974044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Ho WY, Chang J. c. &amp; Ling S -c. Cholesterol dyshomeostasis in amyotrophic lateral sclerosis : cause, consequence, or epiphenomenon ? The FEBS Journal, 1&#x2013;22 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34469619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin U, Park SJ &amp; Park SM Cholesterol metabolism in the brain and its association with Parkinson&#x2019;s disease. Experimental Neurobiology 28, 554&#x2013;567 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6844833</ArticleId><ArticleId IdType="pubmed">31698548</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner M et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature genetics 27, 117&#x2013;120 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11138011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusella J et al. A polymorphic DNA marker genetically linked to Huntington&#x2019;s disease. Nature 306, 234&#x2013;238 (1983).</Citation><ArticleIdList><ArticleId IdType="pubmed">6316146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridge PG, Mukherjee S, Crane PK &amp; Kauwe JSK Alzheimer&#x2019;s disease: Analyzing the missing heritability. PloS one 8, e79771 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820606</ArticleId><ArticleId IdType="pubmed">24244562</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu MH et al. Recessively-Inherited Adult-Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene. Movement Disorders 35, 1662&#x2013;1667 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32374915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciammola A et al. A Novel Mutation of GFAP Causing Adult-Onset Alexander Disease. Frontiers in Neurology 10, 1124 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6851058</ArticleId><ArticleId IdType="pubmed">31781017</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomi H et al. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 14, 29&#x2013;41 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7826639</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian R et al. Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. Journal of Neuropathology and Experimental Neurology 69, 335&#x2013;345 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342699</ArticleId><ArticleId IdType="pubmed">20448479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemann TL et al. Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment. Science Translational Medicine 13, eabg4711 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8730534</ArticleId><ArticleId IdType="pubmed">34788075</ArticleId></ArticleIdList></Reference><Reference><Citation>Acu&#xf1;a AI et al. A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington&#x2019;s disease in mice. Nature Communications 4, 2917 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3905737</ArticleId><ArticleId IdType="pubmed">24336051</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ramahi I et al. High-Throughput Functional Analysis Distinguishes Pathogenic, Nonpathogenic, and Compensatory Transcriptional Changes in Neurodegeneration. Cell Systems 7, 28&#x2013;40.e24 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6082401</ArticleId><ArticleId IdType="pubmed">29936182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochaba J et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proceedings of the National Academy of Sciences of the United States of America 111, 16889&#x2013;16894 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250109</ArticleId><ArticleId IdType="pubmed">25385587</ArticleId></ArticleIdList></Reference><Reference><Citation>Virlogeux A et al. Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington&#x2019;s Disease. Cell Reports 22, 110&#x2013;122 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29298414</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiuri T et al. Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. Human Molecular Genetics 26, 395&#x2013;406 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28017939</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford J et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proceedings of the National Academy of Sciences of the United States of America 106, 22480&#x2013;22485 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2799722</ArticleId><ArticleId IdType="pubmed">20018729</ArticleId></ArticleIdList></Reference><Reference><Citation>Benraiss A et al. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease. Nature Communications 7, 11758 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4899632</ArticleId><ArticleId IdType="pubmed">27273432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood TE et al. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington&#x2019;s disease mouse model. Human Molecular Genetics 28, 487&#x2013;500 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6337698</ArticleId><ArticleId IdType="pubmed">30312396</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi I et al. PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR. Glia 61, 800&#x2013;812 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3657120</ArticleId><ArticleId IdType="pubmed">23440919</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rus Jacquet A et al. The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson&#x2019;s disease. eLife 10, e73062 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514240</ArticleId><ArticleId IdType="pubmed">34590578</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neuroscience 10, 615&#x2013;622 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeb&#xe9;nyi K et al. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nature Neuroscience 24, 1542&#x2013;1554 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553627</ArticleId><ArticleId IdType="pubmed">34675437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia 68, 1046&#x2013;1064 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 50, 274&#x2013;289 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A, McAvoy K, Krishnamurthy K, Trotti D &amp; Pasinelli P Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia 66, 1016&#x2013;1033 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Arredondo C et al. Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons. Neuron 110, 1656&#x2013;1670.e1612 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9119918</ArticleId><ArticleId IdType="pubmed">35276083</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavez-Guti&#xe9;rrez L et al. The mechanism of &#x3b3;-Secretase dysfunction in familial Alzheimer disease. EMBO Journal 31, 2261&#x2013;2274 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3364747</ArticleId><ArticleId IdType="pubmed">22505025</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Cauwenberghe C, Van Broeckhoven C &amp; Sleegers K The genetic landscape of Alzheimer disease: Clinical implications and perspectives. Genetics in Medicine 18, 421&#x2013;430 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4857183</ArticleId><ArticleId IdType="pubmed">26312828</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao MC et al. Single-cell detection of secreted A&#x3b2; and sAPP&#x3b1; from human IPSC-derived neurons and astrocytes. Journal of Neuroscience 36, 1730&#x2013;1746 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4737781</ArticleId><ArticleId IdType="pubmed">26843653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram L &amp; Tanzi RE Genome-wide association studies in Alzheimer&#x2019;s disease. Human Molecular Genetics 18, 137&#x2013;145 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758713</ArticleId><ArticleId IdType="pubmed">19808789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nature genetics 51, 404&#x2013;413 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Strittmatter WJ et al. Apolipoprotein E: High-avidity binding to &#x3b2;-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 90, 1977&#x2013;1981 (1993).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46003</ArticleId><ArticleId IdType="pubmed">8446617</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan AM et al. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (&#x2212;/&#x2212;), and human apoE transgenic mice. Journal of Biological Chemistry 274, 30001&#x2013;30007 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10514484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Basak JM &amp; Holtzman DM The Role of Apolipoprotein E in Alzheimer&#x2019;s Disease Neuron 63, 287&#x2013;303 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044446</ArticleId><ArticleId IdType="pubmed">19679070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523&#x2013;527 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641217</ArticleId><ArticleId IdType="pubmed">28959956</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinohara M et al. Apoe2 is associated with longevity independent of alzheimer&#x2019;s disease. eLife 9, e62199 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588231</ArticleId><ArticleId IdType="pubmed">33074098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YT et al. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer&#x2019;s Disease Phenotypes in Human iPSC-Derived Brain Cell Types. Neuron 98, 1141&#x2013;1154.e1147 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6023751</ArticleId><ArticleId IdType="pubmed">29861287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tcw J et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185, 2213&#x2013;2233.e2225 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9340815</ArticleId><ArticleId IdType="pubmed">35750033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J et al. APOE &#x3f5;4/&#x3f5;4 diminishes neurotrophic function of human iPSC-derived astrocytes. Human Molecular Genetics 26, 2690&#x2013;2700 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886091</ArticleId><ArticleId IdType="pubmed">28444230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J. y. et al. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer&#x2019;s disease (APP/PS1) mice by inhibiting TGF-&#x3b2;/Smad2/STAT3 signaling. Neurobiology of Aging 54, 112&#x2013;132 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28366226</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga M et al. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology. Molecular Neurodegeneration 15, 44 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7389646</ArticleId><ArticleId IdType="pubmed">32727516</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F et al. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer&#x2019;s disease neuropathology. Molecular Neurodegeneration 16, 5 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849119</ArticleId><ArticleId IdType="pubmed">33517893</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugiani O et al. Frontotemporal Dementia and Corticobasal Degeneration in a Family with P301S Mutation in Tau. Journal of Neuropathology and Experimental Neurology 58, 667&#x2013;677 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">10374757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton M et al. Association of missense and 5&#x2019;-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702&#x2013;705 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso ADC, Mederlyova A, Novak M, Grundke-Iqbal I &amp; Iqbal K Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. Journal of Biological Chemistry 279, 34873&#x2013;34881 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15190058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidoryk-Wegrzynowicz M et al. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions. Acta neuropathologica communications 5, 89 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389177</ArticleId><ArticleId IdType="pubmed">29187256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P &amp; Ye Y Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex. Nature Communications 12, 95 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7782792</ArticleId><ArticleId IdType="pubmed">33398028</ArticleId></ArticleIdList></Reference><Reference><Citation>Perea JR et al. Extracellular Monomeric Tau Is Internalized by Astrocytes. Frontiers in Neuroscience 13, 442 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6504834</ArticleId><ArticleId IdType="pubmed">31118883</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG Astroglia and Tau: New Perspectives. Frontiers in Aging Neuroscience 12, 96 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160822</ArticleId><ArticleId IdType="pubmed">32327993</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinchuk A et al. Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer&#x2019;s Disease. Neuron 100, 1337&#x2013;1353.e1335 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309202</ArticleId><ArticleId IdType="pubmed">30415998</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold NC et al. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer&#x2019;s disease. Neurobio Aging 34, 1653&#x2013;1661 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022280</ArticleId><ArticleId IdType="pubmed">23273601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B et al. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer&#x2019;s Disease Progression. Neuron 105, 975&#x2013;991.e977 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318843</ArticleId><ArticleId IdType="pubmed">31926610</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB et al. Large-scale deep multi-layer analysis of Alzheimer&#x2019;s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nature Neuroscience 25, 213&#x2013;225 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825285</ArticleId><ArticleId IdType="pubmed">35115731</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea E et al. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer&#x2019;s disease. Neurobiology of Disease 166, 105655 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9504227</ArticleId><ArticleId IdType="pubmed">35143967</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadick JS et al. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer&#x2019;s disease. Neuron 110, 1788&#x2013;1805.e1710 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9167747</ArticleId><ArticleId IdType="pubmed">35381189</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B et al. The Classical Complement Cascade Mediates CNS Synapse Elimination. Cell 131, 1164&#x2013;1178 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H et al. Single-cell transcriptomic analysis of Alzheimer &#x2018; s disease. Nature 570, 332&#x2013;337 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman A et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer&#x2019;s disease reveals cell-type-specific gene expression regulation. Nature Neuroscience 22, 2087&#x2013;2097 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31768052</ArticleId></ArticleIdList></Reference><Reference><Citation>Orre M et al. Isolation of glia from Alzheimer&#x2019;s mice reveals inflammation and dysfunction. Neurobiology of Aging 35, 2746&#x2013;2760 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25002035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant sod1-mediated ALS. Proceedings of the National Academy of Sciences of the United States of America 112, E6993&#x2013;E7002 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>SantaCruz KS, Yazlovitskaya E, Collins J, Johnson J &amp; DeCarli C Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer&#x2019;s disease. Neurobiology of Aging 25, 63&#x2013;69 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14675732</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiwaji Z et al. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and A&#xdf; pathology. Nat Commun 13, 135 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8748982</ArticleId><ArticleId IdType="pubmed">35013236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceyz&#xe9;riat K et al. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer&#x2019;s disease. Acta neuropathologica communications 6, 104 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6190663</ArticleId><ArticleId IdType="pubmed">30322407</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenbach N et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer&#x2019;s disease model. EMBO Molecular Medicine 11, e9665 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6365929</ArticleId><ArticleId IdType="pubmed">30617153</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemaud O et al. Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease. Neurobiology of Aging 90, 135&#x2013;146 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32171592</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA et al. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nature Communications 11, 3753 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasel P, Rose IVL, Sadick JS, Kim RD &amp; Liddelow SA Neuroinflammatory astrocyte subtypes in the mouse brain. Nature Neuroscience 24, 1475&#x2013;1487 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34413515</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynard KR et al. Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex. Nature Neuroscience 24, 425&#x2013;436 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8095368</ArticleId><ArticleId IdType="pubmed">33558695</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364, 89&#x2013;93 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB et al. Large-scale Proteomic Analysis of Alzheimer&#x2019;s Disease Brain and Cerebrospinal Fluid Reveals Early Changes in Energy Metabolism Associated with Microglia and Astrocyte Activation. Nature medicine 26, 769&#x2013;780 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V et al. Identification of Conserved Proteomic Networks in Neurodegenerative Dementia. Cell Reports 31, 107807 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221021</ArticleId><ArticleId IdType="pubmed">32579933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan YW et al. Meta-Analysis of the Alzheimer&#x2019;s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Reports 32, 107908 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428328</ArticleId><ArticleId IdType="pubmed">32668255</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong F, Ge W &amp; Ma C Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s &amp; Dementia 15, 429&#x2013;440 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30502339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz FI, Dieterich DC &amp; Schuman EM Teaching old NCATs new tricks: using non-canonical amino acid tagging to study neuronal plasticity. Current Opinion in Chemical Biology 17, 738&#x2013;746 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321483</ArticleId><ArticleId IdType="pubmed">23938204</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Cho KF, Cavanagh PE &amp; Ting AY Deciphering molecular interactions by proximity labeling. Nature Methods 18, 133&#x2013;143 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33432242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H-G, Wheeler MA &amp; Quintana FJ Function and therapeutic value of astrocytes in neurological diseases. Nature Reviews Drug Discovery 21, 339&#x2013;358 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9081171</ArticleId><ArticleId IdType="pubmed">35173313</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossel KA et al. Incidence and impact of subclinical epileptiform activity in Alzheimer&#x2019;s disease. Ann Neurol 80, 858&#x2013;870 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5177487</ArticleId><ArticleId IdType="pubmed">27696483</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath AA et al. Subclinical epileptiform activity accelerates the progression of Alzheimer&#x2019;s disease: A long-term EEG study. Clinical Neurophysiology 132, 1982&#x2013;1989 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34034963</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza Monteiro de Araujo D, Nassini R, Geppetti P &amp; De Logu F. TRPA1 as a therapeutic target for nociceptive pain. Expert Opin Ther Targets 24, 997&#x2013;1008 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610834</ArticleId><ArticleId IdType="pubmed">32838583</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajani V, Zhang Y, Revill AL &amp; Funk GD The role of P2Y1 receptor signaling in central respiratory control. Respiratory Physiology &amp; Neurobiology 226, 3&#x2013;10 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26476057</ArticleId></ArticleIdList></Reference><Reference><Citation>Onur TS et al. Downregulation of glial genes involved in synaptic function mitigates Huntington&#x2019;s disease pathogenesis. eLife 10, e64564 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8149125</ArticleId><ArticleId IdType="pubmed">33871358</ArticleId></ArticleIdList></Reference><Reference><Citation>Moruno-Manchon JF et al. Sphingosine kinase 1-associated autophagy differs between neurons and astrocytes. Cell Death and Disease 9, 521 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5943283</ArticleId><ArticleId IdType="pubmed">29743513</ArticleId></ArticleIdList></Reference><Reference><Citation>Laug D et al. Nuclear factor I-A regulates diverse reactive astrocyte responses after CNS injury. The Journal of Clinical Investigation 129, 4408&#x2013;4418 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763246</ArticleId><ArticleId IdType="pubmed">31498149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisholm NC et al. Histone methylation patterns in astrocytes are influenced by age following ischemia. Epigenetics 10, 142&#x2013;152 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4622874</ArticleId><ArticleId IdType="pubmed">25565250</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Yin K, Zhang Q, Gao C &amp; Qiu JL Modulating chromatin accessibility by transactivation and targeting proximal dsgRNAs enhances Cas9 editing efficiency in vivo. Genome Biology 20, 145 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6660936</ArticleId><ArticleId IdType="pubmed">31349852</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton IB et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase Activates Genes From Promoters and Enhancers. Nature Biotechnology 33, 510&#x2013;517 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430400</ArticleId><ArticleId IdType="pubmed">25849900</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito G et al. Autologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in &#x3b2; amyloid-induced neurodegeneration. Scientific Reports 6, 22605 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4778118</ArticleId><ArticleId IdType="pubmed">26940982</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian H et al. Reversing a model of Parkinson&#x2019;s disease with in situ converted nigral neurons. Nature 582, 550&#x2013;556 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521455</ArticleId><ArticleId IdType="pubmed">32581380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H et al. Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice. Cell 181, 590&#x2013;603.e516 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32272060</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LL et al. Revisiting astrocyte to neuron conversion with lineage tracing in vivo. Cell 184, 5465&#x2013;5481.e5416 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8526404</ArticleId><ArticleId IdType="pubmed">34582787</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchi R, Masserdotti G &amp; G&#xf6;tz M Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches. Neuron 110, 366&#x2013;393 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34921778</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrich C et al. Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex. Stem Cell Reports 3, 1000&#x2013;1014 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4264057</ArticleId><ArticleId IdType="pubmed">25458895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitter BD, Cox LM, Rydel RE &amp; May PC Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proceedings of the National Academy of Sciences 92, 10738&#x2013;10741 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40687</ArticleId><ArticleId IdType="pubmed">7479875</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ Alzheimer&#x2019;s Disease. Cold Spring Harb Perspect Biol 3, a004457 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119915</ArticleId><ArticleId IdType="pubmed">21576255</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ Treatments for Alzheimer&#x2019;s disease emerge. Science 373, 624&#x2013;626 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34353940</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson IA, Chundu KR, Davies-Hill T, Honer WG &amp; Davies P Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer&#x2019;s disease. Annals of Neurology 35, 546&#x2013;551 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8179300</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson JE et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiology of Aging 31, 578&#x2013;590 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">18586353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcock DM, Vitek MP &amp; Colton CA Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer&#x2019;s disease. Neuroscience 159, 1055&#x2013;1069 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2699894</ArticleId><ArticleId IdType="pubmed">19356689</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29, 824&#x2013;828 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O et al. Amyotrophic lateral sclerosis. Nature Reviews Disease Primers 3, 17071 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Izrael M, Slutsky SG &amp; Revel M Rising Stars : Astrocytes as a Therapeutic Target for ALS Disease. Frontiers in Neuroscience 14, 824 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399224</ArticleId><ArticleId IdType="pubmed">32848579</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Martin LJ &amp; Kuncl RW Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis. New England Journal of Medicine 326, 1464&#x2013;1468 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D, Cordera S, Cavalla P &amp; Migheli A Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 139, 27&#x2013;33 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyant KJ, Ridder AJ &amp; Dayalu P Huntington&#x2019;s Disease&#x2014;Update on Treatments. Current Neurology and Neuroscience Reports 17, 33 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28324302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A &amp; Schwarzschild MA The epidemiology of Parkinson&#x2019;s disease: risk factors and prevention. The Lancet Neurology 15, 1257&#x2013;1272 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27751556</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki I &amp; Asanuma M Neuron-Astrocyte Interactions in Parkinson&#x2019;s Disease. Cells 9, 2623 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7762285</ArticleId><ArticleId IdType="pubmed">33297340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tysnes O-B &amp; Storstein A Epidemiology of Parkinson&#x2019;s disease. Journal of neural transmission 124, 901&#x2013;905 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28150045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H &amp; Takahashi H NACP/&#x3b1;-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson&#x2019;s disease brains. Acta Neuropathologica 99, 14&#x2013;20 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10651022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>